This is the authors' abstract. We don't add key points for this paper.
Background: The use of nanomaterial-based radiosensitizers to improve the therapeutic ratio has gained attraction in radiotherapy. Increased radiotoxicity applied to the tumor region may result in adverse impact on the unexposed normal cells to the radiation, a phenomenon known as radiation-induced bystander effect (RIBE). Objectives: @BSA nanoparticles (NPs) as radiosensitizers on the enhancement of bystander response in non-irradiated cells. Materials and Methods: @BSA NPs. The irradiated-cell's conditioned medium (ICCM) was collected and incubated with MCR-5 human fetal lung fibroblasts. Results: <0.05), but the efficacy was not statistically significant after 8-Gy Irradiation. Conclusion: The results indicated that the presence of NPs did not affect bystander response enhancement at higher concentrations. These findings highlighted the potential use of radiation-enhancing agents and their benefits in radiotherapy techniques with high doses per fraction.
No takes yet. Share an insight, caveat, or question.
Nasehi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: